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p27Kip1 regulates the decision to enter into S-phase or
withdraw from the cell cycle by establishing an inhibi-
tory threshold above which G1 cyclin-dependent kinases
accumulate before activation. We have used the HL-60
cell line to study regulation of p27 as cells withdraw
from the cell cycle following treatment with 12-O-tetra-
decanoylphorbol-13-acetate (TPA). We found that the
amount of p27 is maximal in G0 cells, lower in G1 cells,
and undetectable in S-phase cells. In contrast to the
protein, the amount of p27 mRNA was the same in these
populations, suggesting that accumulation of p27 during
the cell cycle and as cells withdraw from the cell cycle is
controlled by post-transcriptional mechanisms. In
S-phase cells, the degradation of p27 appears to predom-
inate as a regulatory mechanism. In G0 cells, there was an
increase in the synthesis rate of p27. Our data demon-
strate that, in G0 cells, accumulation of p27 is due to an
increase in the amount of p27 mRNA in polyribosomes.
The activation status of the cyclin-dependent kinases
(CDKs)1 regulates progression through G1 (1). The phosphoryl-
ation of the Rb protein correlates with transition through the
restriction point when cells commit irreversibly to S-phase and
subsequent cell division (2). Rb is phosphorylated by cyclin
DzCDK complexes early in G1, and cyclin EzCDK2 complexes
further phosphorylate and maintain the hyperphosphorylated
state through the remainder of G1 (3). A class of proteins that
interact with both G1 CDKs, called Kips (CDK inhibitory pro-
teins), might coordinate these two classes of kinases and the
start of S-phase. p27Kip1 might directly bridge the activation of
cyclin EzCDK2 complexes to expression of cyclin DzCDK com-
plexes (4, 5). p21Kip1 might regulate cyclinzCDK2 complexes at
a checkpoint following DNA damage or nucleotide pool pertur-
bation (6–8). The function of p57Kip2 is unclear at this time.
Many observations suggest that p27 is a key regulator con-
trolling entry into and exit from the cell cycle. Regardless of cell
type or condition used to achieve growth arrest, an increase in
the amount of p27zCDK2 complexes is a common feature of
non-proliferating cells (9). In addition, ectopic expression of p27
in cells leads to G0/G1 arrest (10, 11), and antisense vectors
that block p27 lead to an increase in the percentage of cells in
S-phase (12). Furthermore, the phenotypes of Kipl mice sug-
gest that the loss of p27 leads to an alteration in the balance
between proliferating and non-proliferating cells (13–15). The
stoichiometric nature of p27-mediated inhibition has led to the
proposal that p27 functions to establish an inhibitory threshold
above which CDKs accumulate before their activity can drive
the cell cycle (16).
There are multiple mechanisms to regulate the amount of
p27 available for interaction with cyclinzCDK2 complexes, de-
pendent both on the cell type and the condition that leads to
growth arrest. First, in proliferating cells, cyclin DzCDK com-
plexes sequester the CDK2-inhibitory activity of p27. In prolif-
erating mink lung epithelial cells (Mv1Lu) p27 associates with
cyclin D2zCDK4 complexes (4). Exposure of Mv1Lu cells to
transforming growth factor-b or growth to confluence leads to a
displacement of p27 from cyclin DzCDK4 complexes, allowing it
to associate with and inhibit the cyclinzCDK2 complex (17). In
proliferating MANCA cells, p27 associates with cyclin D com-
plexes in a non-inhibitory manner (5). Second, changing the
amount of p27 mRNA can control accumulation of p27 protein;
increased accumulation of p27 mRNA contributes to the in-
crease in p27 protein following exposure of U937 cells to vita-
min D3 (18). Third, ubiquitin-mediated degradation contrib-
utes to p27 accumulation in quiescent IMR-90 and MG-63 cells
(19). We now demonstrate a fourth mechanism of p27 regula-
tion that involves translation control, regulating association of
p27 mRNA with polyribosomes.
EXPERIMENTAL PROCEDURES
Cell Culture, mRNA, and Protein Analysis—HL-60 cells were main-
tained at 2–5 3 105/ml in RPMI plus 10% fetal calf serum. Under these
conditions, all cells incorporated bromodeoxyuridine during a 27-h la-
beling period (data not shown). To achieve growth arrest, cells were
treated with 33 nM TPA. To obtain synchronized cell cycle fractions, 4
liters of cells were grown and elutriated as we described (20). DNA
content was determined by propidium iodide staining as described (20).
RNA was isolated from cells using RNA-STAT 60 following the recom-
mendations of the manufacturer, and 20 mg of total RNA was used for
Northern blotting as described (5). Proteins were isolated by sonicating
cells in Tween lysis buffer as described (5). Immunoblot and kinase
assays were performed as described previously (5, 20). To quantita-
tively determine the amount of protein using enhanced chemilumines-
cence (ECL), we included a standard protein curve in all experiments.
This allowed us to determine a suitable range for quantitation based on
the linear relationship between amount of protein and the intensity of
signal. Signal quantitation was performed by spot densitometry using
an IS1000 digital imaging system (Alpha-Innotech).
Accumulation of p27 in Cells Exposed to LLnL—Either following
elutriation of an asynchronous population into cell cycle phase synchro-
nized fractions or 48 h after TPA-treatment of an asynchronous popu-
lation of cells, the G0, G1, or S-phase cells were exposed to either 2 mg/ml
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LLnL (19) in Me2SO or an equivalent volume of Me2SO for 3 h. Extracts
were prepared from treated and untreated cells, and proteins were
either directly resolved by electrophoresis on a 10% SDS-polyacryl-
amide gel or immunoprecipitated using an excess amount of p27 anti-
body. The proteins were then transferred to Immobilon (Millipore
Corp.), and p27 was detected by immunoblotting. Spot densitometry
was performed, and the increase in p27 was measured.
Metabolic Labeling—G0, G1, and S-phase cells were isolated and
treated with LLnL for 90 min in medium containing 1 mCi/ml Amer-
sham Promix at a density of 4 3 106 cell/ml. Cells were washed twice in
phosphate-buffered saline and lysed in RIPA buffer (50 mM Tris, pH 8.0,
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
5 mM EDTA, pH 8.0) containing 10 mg/ml each aprotinin, leupeptin,
soybean trypsin inhibitor, and pepstatin, and 1 mM phenylmethylsul-
fonyl fluoride. A small aliquot was removed, protein was precipitated
with TCA, and the amount of radioactivity incorporated was quanti-
tated in a scintillation counter. Immunoprecipitations were normalized
for incorporated radioactivity, and proteins were resolved on a 12%
SDS-polyacrylamide gel. After autoradiography, the p27 band was ex-
cised, and radioactivity was measured.
Differential Polysome Association—To examine polysome association
of mRNA, we treated cells with 100 mg/ml cyclohexamide for 15 min
prior to harvesting, collected 4 3 107 cells by centrifugation, and
washed the pellet twice with ice-cold phosphate-buffered saline contain-
ing 100 mg/ml cyclohexamide. Cells were lysed in 1 ml of lysis buffer
(150 mM NaCl, 1.5 mM MgCl2, 150 mg/ml cyclohexamide, 20 mM dithi-
othreitol) containing 0.5% Nonidet P-40 and 1 mM phenylmethylsulfo-
nyl fluoride. Nuclei and cell debris were removed by centrifugation at
13,000 3 g for 5 min at 4 °C. We added 1.5 mg of heparin to the
supernatant and applied this to the top of a 10-ml 15–40% continuous
sucrose gradient. The gradient was prepared in lysis buffer containing
1.5 mg/ml heparin. Gradients were resolved by centrifugation at 38,000
rpm in an SW41 rotor for 1.5 h at 4 °C, and 1-ml fractions were
collected. The fractionation of ribosomes was assessed by UV absorb-
ance and ethidium bromide staining of agarose gels.
To quantitate the amount of p27 mRNA in each fraction, we blotted
400 ml (;40% of the total) to nitrocellulose and fixed the membrane in
10% formalin before UV cross-linking. Membranes were probed with a
random primed human p27 cDNA. Quantitation was performed using a
phosphoimager (Fuji MacBas 2000, Version 2.0).
To control for the specificity of our p27 probe, we also performed
RT-PCR. Each fraction was adjusted to 1% SDS and 10 mM EDTA and
150 ng of proteinase K was added. The fractions were subsequently
incubated for 30 min at 37 °C, and then RNA was purified, following
phenol/chloroform extraction, on Nensorb 20 nucleic acid purification
cartridges as described by the manufacturer (Dupont NEN). RNA was
reverse-transcribed using random 9-mer primers (Stratagene) and M-
MLV reverse transcriptase. The RT product was subsequently ampli-
fied with specific p27 primers (59-TTGCAGGAACCTCTTCGGCC-39 and
59-GGTCGCTTCCTTATTCCTGC-39) for 40 to 45 cycles using AmpliTaq
(Perkin-Elmer). PCR reactions were initiated with a 94 °C 5-min incu-
bation and then cycled through 94 °C for 90 s, 55 °C for 60 s, and 72 °C
for 120 s. PCR was completed with a 15-min extension at 72 °C. Fol-
lowing PCR, an aliquot of product was loaded onto an agarose gel,
transferred to nylon membranes, and probed with random primer-
labeled p27 cDNA probes.
For detection of GAPDH, one half of the RNA from each fraction was
loaded directly onto agarose gels, and Northern blotting was performed
with a random primer-labeled GAPDH probe. Data was collected di-
rectly either by autoradiography or by phosphoimager (Fuji Mac-
Bas2000, Version 2.0).
RESULTS
Cell Cycle-dependent and Growth-dependent Post-transcrip-
tional Regulation of p27 in HL-60 Cells—The decision to either
proliferate or withdraw from the cell cycle is made during G1
phase and is affected by the relative amounts of cyclinzCDK
complexes and CDK inhibitors (18, 21–25). We used HL-60
cells to study the mechanisms controlling cell cycle withdrawal
during differentiation because we could isolate populations of
cells in each phase of the cell cycle in sufficient quantities for
biochemical analysis. HL-60 cells differentiate into monocytes
in the presence of TPA (26). Proliferation in asynchronous
cultures of HL-60 cells completely ceased within 36 h following
exposure to TPA, and typically, greater than 90% of the treated
cells arrested with a G1 content of DNA (Fig. 1A). The signifi-
cance of the 10% of cells arrested in G2/M is unclear. TPA
treatment of enriched G1 or S-phase populations obtained by
centrifugal elutriation suggested that cells arrested in a single
cell cycle (Table I) at the next G1 phase. The 15% reduction of
G1 cells following TPA treatment of elutriated G1 cells is con-
sistent with a TPA restriction point subdividing this phase of
FIG. 1. In HL-60 cells, activation of PKC leads to growth arrest and induction of p27. A, flow cytometry. Asynchronous cultures of HL-60
cells were exposed to 33 nM TPA, and aliquots were removed at 6-h intervals as indicated on the right and processed for flow cytometry. B, CDK2
kinase activity is diminished in TPA-treated cells. Cell lysates were prepared, and the ability of CDK2 immunoprecipitates to phosphorylate
histone H1 was measured. The lanes are labeled to correspond with panel A. C, p27 protein increases without a change in the amount of p27 mRNA.
Protein and RNA were isolated from cell lysates, and the amount of p27 was determined by immunoblot (top) and Northern blotting (bottom). The
lanes are labeled to correspond with panel A. p27 protein was detected with an affinity purified p27-specific antibody. Northern blots were probed
with either p27 or GAPDH cDNA as indicated on the right.
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the cell cycle. Concomitant with accumulation of cells with a G1
content of DNA following exposure to TPA, there was a coordi-
nated decrease in immunoprecipitable CDK2 kinase activity
(Fig. 1B) and an induction of p27 protein (Fig. 1C). The amount
of p27 mRNA remained the same (Fig. 1C). Similar results were
obtained with the phase-enriched populations (data not shown).
Since TPA-treated cells arrest with a 2C DNA content, p27
might accumulate in these cells as an indirect consequence of
G1 arrest in a state where p27 protein is stabilized. To address
this, we first determined whether p27 expression is cell cycle
regulated. We obtained cell cycle phase-specific populations of
HL-60 cells by centrifugal elutriation of asynchronous cultures
and examined p27 protein expression (Fig. 2). This method
does not induce perturbations in cell cycle-regulated protein
expression often observed with drug or metabolic-induced cell
cycle synchronization. The amount of p27 protein was maximal
during the G1 phase of the cell cycle (Fig. 2B). The amount of
p27 protein detected was linearly dependent on the amount of
cell extract subjected to immunoprecipitation (data not shown;
but see Fig. 3A). The amount of p27 mRNA did not change
during the cell cycle (data not shown). These data suggest that,
during the unperturbed cell cycle, p27 levels are determined by
a post-transcriptional mode of regulation. However, the
amount of p27 in equal numbers of G0 and G1 cells was quite
different (Fig. 3A). G0 cells contained at least 3–4-fold more
p27 than G1 cells. We obtained similar results comparing the
amount of p27 as a function of total protein rather than cell
number (data not shown). The amount of p27 detected was
linearly dependent on the amount of cell extract subjected to
immunoprecipitation (Fig. 3A, compare lanes 1 and 2). To-
gether, these data suggest that accumulation of p27 reflected
post-transcriptional regulation during both the G1/G0 and G1/S
transitions.
Phase-dependent Changes in Synthesis of p27—The accumu-
lation of p27 represents the sum of protein synthesis and pro-
tein degradation. Precedence exists for the regulation of pro-
tein half-life as a function of cell cycle phase during both the
G1/S transition (27) and at the metaphase/anaphase transition
(28). Determination of protein half-life during specific phases of
the cell cycle is problematic because traversal of the cell cycle
phases during the chase period will obscure the measured
value. Consequently, to define the post-transcriptional mecha-
nisms regulating p27, we measured the accumulation of p27
and the actual synthesis of p27 in G0, G1, and S-phase cells
treated with LLnL (N-acetyl-leucinyl-leucinyl-norleucinal-H),
an inhibitor that binds to the chymotryptic site on the protea-
some. To measure accumulation of p27, we titrated each ex-
tract against recombinant p27 over a 16-fold range using 2-fold
serial dilution. The resulting autoradiograph was analyzed by
spot densitometry using an IS-1000 digital imaging system
(Alpha Innotech), and we compared only those points that fell
within the linear range (established by comparing signal inten-
sity to amount of recombinant protein). Although the amount of
p27 increased in all populations treated with LLnL, consistent
with detection of newly synthesized p27 (shown below), the mag-
nitude of the increase was cell cycle phase-specific (Fig. 3B).
The increase in p27 levels was greatest in S-phase cells (about
160%) and more moderate in G1 and G0 cells (both about 50%).
To measure the amount of p27 synthesis in each population
treated with LLnL, we labeled cells with 35S-methionine and
-cysteine for 90 min and immunoprecipitated p27. The short
labeling period ensured that synchronized cells did not pro-
gress into the next phase of the cell cycle and inclusion of LLnL
would prevent protein degradation; however, cells within G1
phase might traverse the restriction point during this period.2
After normalizing lysates for total protein synthesis, we iso-
lated p27 with affinity purified p27-specific antibodies. We
quantitated the amount of p27 synthesis by scintillation count-
ing of excised bands, normalizing incorporation to 100% in G1
cells. We found that the amount of newly synthesized p27 was
greatest in G0 cells and lower in G1 and S-phase cells (Fig. 3C).
We were unable to demonstrate if LLnL affected synthesis of
p27 in a cell cycle phase-specific manner; however, similar
increases in translation of p27 have been reported in other
systems where LLnL was not included (29, 30). This suggested
that the actual rate of p27 synthesis increased in G0 cells.
Increased Synthesis of p27 Occurs as a Consequence of an
Increase in the Amount of p27 mRNA in Polyribosomes—To
determine the mechanism responsible for accumulation of p27
in G0 cells, we compared the association of p27 mRNA with
polysomes in proliferating and TPA-treated cells. To accom-
plish this, we fractionated RNA on continuous sucrose gradi-
ents and monitored the UV absorbance of the ribonucleoprotein
complexes at A254. In this assay, RNA equilibrates within the
gradient as a function of the associated proteins; polysomal
RNA equilibrates in the densest regions of the gradient. The
2 S. S. Millard, J. S. Yan, H. Nguyen, M. Pagano, H. Kiyokawa, and A.
Koff, unpublished data.
FIG. 2. The expression of p27 is reg-
ulated during the cell cycle. A, Flow
cytometry. Asynchronous cultures of
HL-60 cells were elutriated into cell cycle
phase-specific fractions. DNA content was
determined by propidium iodide. Frac-
tions are numbered on the right. B, accu-
mulation of p27 protein is maximal dur-
ing G1 phase of the cell cycle. p27 was
immunoprecipitated from each fraction of
cells indicated at the top of each lane. The
lanes are numbered to match panel A. A
mock immunoprecipitation with a rabbit-
anti mouse antibody (RaM) is shown.
TABLE I
Percent of population with a G0/G1 DNA content
Numbers represent the mean of two independent experiments.
Time
S-phase fraction G1 phase fraction
1TPA 2TPA 1TPA 2TPA
h
0 34.3 91.0
6 30.7 36.2 86.8 87.5
12 18.8 56.5 79.7 74.6
18 30.7 56.5 75.0 62.0
24 61.4 44.4 74.2 40.3
30 70.8 87.2
36 78.4 92.0
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extent of polysomal association is a reflection of the rate of
protein synthesis; increased association reflects either an in-
crease in the rate of initiation or an increase in the rate of
elongation. To quantitate the p27 mRNA, we dot-blotted each
fraction of the gradient and probed the membranes with a p27
cDNA probe. In untreated cells, p27 mRNA distributed in the
free mRNA fraction of the gradient and in fractions containing
monosomes and small polysomes (Fig. 4B). In TPA-treated cells,
p27 mRNA distributes throughout the gradient, with the great-
est differences occurring in the densest region of the gradients.
Treatment of cells with puromycin will disrupt polysomes
and lead to an accumulation of mRNA in monosome and sub-
unit fractions of the gradient. When we exposed TPA-treated
cells to puromycin, the p27 mRNA shift was eliminated, con-
firming polysome association (Fig. 4B). We found approxi-
mately 60% more p27 mRNA associated with polysomes in
TPA-treated cells (Fig. 4D). This increase appears to occur at
the expense of the monosome and small polysome associated
mRNA (Fig. 4D), suggesting that p27 synthesis might be reg-
ulated at the level of translation elongation. We were unable to
detect a significant change in the distribution of p27 mRNA in
polyribosomes isolated from G1 and S-phase cells, consistent
with our observation that p27 synthesis, in the presence of the
proteasome inhibitor LLnL, was approximately equal in these
populations (data not shown).
We confirmed the specificity of the dot-blot by isolating RNA
from sucrose gradients and performing RT-PCR with p27-spe-
cific oligonucleotide primers. In this experiment, we assessed
polysomal fractionation by ethidium bromide staining and de-
tection of 28 and 18 S rRNA following agarose gel electrophore-
sis (Fig. 5). Consistent with our dot blot results, we found a
shift in the distribution of p27 mRNA with a substantial
amount fractionating with heavier polysomes in TPA-treated
cells (Fig. 5). We confirmed that the PCR product was p27 by
restriction endonuclease mapping (data not shown). Further-
more, addition of a control DNA encoding p27 but missing 100
base pairs of the sequence between the primer binding sites
was specifically amplified (data not shown).
To ensure that the change of p27 migration into heavier
polysomes did not represent a nonspecific change in bulk trans-
lation, we directly probed fractionated RNA with GAPDH.
There was little change in the migration of GAPDH mRNA
following TPA treatment, either in the RT-PCR analysis (Fig.
5) or dot-blotting procedure (Fig. 4C). This suggests that the
changes in polysome distribution of p27 mRNA were specific
and did not reflect general changes that cells might undergo
during alternative developmental pathways. Together, these
experiments demonstrate that increased expression of p27 pro-
FIG. 3. Cell cycle phase-specific post-transcriptional regulation of p27. A, p27 protein accumulates in G0 cells. G0 cells were obtained
following 48 h of treatment with TPA. G1 and S-phase cells were obtained by centrifugal elutriation of asynchronous cultures. p27 and GAPDH
mRNA were detected by Northern blotting and visualized on a Fuji phosphoimager using MacBas 2000 software. The amount of p27 mRNA is
constant during these phases of the cell cycle (top panels, lanes 2–4). In the bottom panel, p27 was immunoprecipitated from 1 mg of each extract
(lanes 2–4) and detected by immunoblotting. To ensure that excess antibody was used in the immunoprecipitation, 3 mg of G0 extract was
immunoprecipitated under the same conditons (lane 1). The amount of p27 is greatest in G0 cells, minimal in S-phase cells, and intermediate in
G1 cells. B, accumulation of p27 in the presence of LLnL. Cells were treated with LLnL for 3 h prior to lysis. p27 was quantitated by
immunoblotting. On the ordinate, we plotted the LLnL-dependent increase in p27. This experiment was repeated four times with comparable
results, and the data presented is from a single representative experiment. Linearity was confirmed by including a titration of known amounts of
recombinant p27 in the immunoblot. For quantiation of p27 accumulation in G1 and S-phase cells, we compared the accumulation at 3 h in the
presence and absence of LLnL. p27 accumulates to the greatest extent in G0 phase cells. C, synthesis of p27 is maximal in cells treated with TPA.
The p27 bands were excised from an SDS-polyacrylamide gel (shown below the graph), and the amount of radioactivity incorporated was measured
by scintillation counting. Background was determined individually for each lane in a similar manner. On the ordinate, we plotted incorporation
of radioactivity into p27 relative to the amount in G1 cells.
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tein in cells exposed to TPA could be attributed to an increase
in the density of ribosomes associated with p27 mRNA.
DISCUSSION
To study how the p27-mediated CDK inhibitory threshold is
modulated during G1, we explored the mechanisms regulating
p27 as HL-60 cells withdraw from the cell cycle or enter S-
phase. We have analyzed synchronous cell populations in G0,
G1, or S-phase. We have shown that the translation of p27
changes in a growth-dependent manner, the association of p27
mRNA with polysomes is a determinant of the accumulation of
p27 protein. Furthermore, degradation of p27 is a major deter-
minant of accumulation of p27 during the G1/S transition.
We found that an increase in the rate of p27 protein synthe-
sis modulates the amount of p27 as HL-60 cells withdraw from
the cell cycle. First, the amount of p27 is higher in growth-
arrested cells than in G1 cells although the amount of mRNA
remained the same. Second, the p27 synthesis rate is increased
in G0 cells compared with either G1 or S-phase cells when
proteolysis was prevented by treating cells with LLnL. Third,
the polysome distribution of p27 mRNA shifts to heavier frac-
tions in G0 cells, representing a greater density of actively
translating ribosomes on each mRNA. This type of polysome
distribution might represent more efficient utilization of the
p27 mRNA template either by altering the initiation or elon-
gation phases of translation. Translation control is not unique
to either TPA or differentiating HL-60 cells. Hengst and Reed
FIG. 4. p27 mRNA is distributed to
heavier polysomes in TPA-treated
cells. A, sucrose gradient tracings. Cells
were cultured with (right panel) or with-
out TPA (left panel) as described under
“Experimental Procedures.” Puromycin
(150 mg/ml) was added 45 min prior to
harvesting. Fractions were collected from
the bottom of the gradient, and the A254
was measured during fractionation. Solid
lines represent the absorbance in the ab-
sence of puromycin, and dashed lines rep-
resent the absorbance in the presence of
puromycin. B, quantitation of p27 mRNA
in fractions of a representative sucrose
gradient. The amount of mRNA in each
fraction was measured by determining
the amount of probe hybridized to dot-
blots of each fraction on a phosphoimager
and plotting the value as a percent of total
p27 mRNA signal. In the left panel, con-
trol (white) and TPA-treated (black) gra-
dients were compared. In the right panel,
cells were treated with puromycin before
collection and comparison of the p27
mRNA amounts. Results are representa-
tive of seven separate experiments. C,
TPA increases the polysomal associated
p27 mRNA 60%. Shown is the quantita-
tion of GAPDH mRNA in each fraction of
the sucrose gradients. Labeling is as de-
scribed in panel B. D, the increase in poly-
somal mRNA occurs as a consequence of
more efficient conversion of monosome
and subunit-associated mRNA into poly-
somes. We compared the total amount of
puromycin-sensitive p27 mRNA, the free
mRNA (determined on ethidium bromide-
stained cells by absence of both 28 and 18
S rRNA species in the fraction), and the
remaining fractions. These values are
tabulated (mean 6 S.E.).
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(29) reported translation regulation of p27 in both lovastatin-
arrested HeLa cells and confluent human diploid fibroblasts,
and Agrawal et al. (30) showed that platelet-derived growth
factor treatment of BALB/c 3T3 cells represses translation of
p27 mRNA. Our data expands this observation to events fol-
lowing the programmed withdrawal of a cell from the cell cycle
into a terminally differentiated state.
There are many examples where mRNA interaction with
polysomes occurs as cells re-enter the cell cycle from a non-
proliferative state (31, 32). In contrast, p27 mRNA appears to
be a member of a small group of messages that interact more
efficiently with the translation apparatus as cells withdraw
from the cell cycle. The mechanism regulating association is
unclear. Factors might either promote ribosome association
with p27 mRNA in G0 cells or antagonize the association in
non-G0 cells. There is precedence for factors operating at se-
quences located in non-translated regions that might control
ribosome association (32–36) or subcellular localization (37,
38). Alternatively, ribosomal proteins specific to non-prolifer-
ating cells might eliminate secondary structures in the p27
mRNA, allowing it to interact efficiently with ribosomes. The
eIF-4E helicase facilitates unwinding and ribosomal associa-
tion of mRNAs required to enter the cell cycle (38, 39). A
presumptive factor regulating p27 mRNA association might act
in a similar fashion, but with opposite biologic effect, and
selectively recruit G0-specific mRNA. However, we favor a
model in which an inefficient repressor of translation is allevi-
ated as cells withdraw from the cell cycle because there is trans-
lation occurring in proliferating cells, albeit less efficiently than
in non-proliferating cells. Future experiments are underway to
explore the mechanism regulating p27 translation.
The degradation of proteins is a key regulatory mechanism
controlling protein expression as cells traverse the cell cycle
(40). Substantial evidence has accumulated to support the cru-
cial role of proteolysis at the metaphase/anaphase transition.
Likewise, the involvement of a proteasome at the G1/S transi-
tion has been implicated in Saccharomyces cerevisiae (27, 41,
42). We have shown that the amount of p27 decreases precip-
itously at the G1/S transition although the synthesis of p27
remained the same. Furthermore, p27 accumulates to a similar
extent when LLnL is added to either G1 or S-phase cells. These
observations suggest that protein degradation controls p27 ac-
cumulation during the cell cycle, and the amount of LLnL used
in our experiments is sufficient to inhibit that proteasome
activity. Confirmation of this hypothesis, however, awaits the
ability to measure the half-life of p27 in cell cycle phase-specific
extracts capable of degrading p27.
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FIG. 5. Specificity of p27 mRNA detection and distribution in
the gradients. The sucrose gradient is represented by the triangle. At
the top, ethidium bromide-stained agarose gels indicate the migration
of the 18 and 28 S rRNA species after centrifugation of untreated and
treated cells as indicated on the right. The middle panel, shows the
Southern blot of the amplified p27 product in untreated and TPA-
treated cells as indicated on the right. The bottom panel shows direct
Northern blotting of GAPDH from untreated and TPA-treated cells
indicated on the right.
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